List of MediciNova patents

List of MediciNova patents

List of Basf Catalysts patents

List of MyFitnessPal patents

List of University of Massachusetts patents

Companies in the Copper, Nickel, Lead, and Zinc Mining industry

Vector database venture capital investors

Patents where

Current Assignee

Name

is

MediciNova

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11446283 Methods and dosing regimens using ibudilast and a second agent for cancer therapy	Patent 11446283 was granted and assigned to MediciNova on September, 2022 by the United States Patent and Trademark Office.	MediciNova	MediciNova		United States Patent and Trademark Office	11446283	September 20, 2022
	‌ US Patent 8138201 Treatment of progressive neurodegenerative disease with ibudilast	Patent 8138201 was granted and assigned to MediciNova on March, 2012 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	8138201	March 20, 2012
	‌ US Patent 7429617 Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis	Patent 7429617 was granted and assigned to MediciNova on September, 2008 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7429617	September 30, 2008
	‌ US Patent 7728169 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use	Patent 7728169 was granted and assigned to MediciNova on June, 2010 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7728169	June 1, 2010
	‌ US Patent 8119657 Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-α]pyridin-3-yl)propan-1-one and related methods	Patent 8119657 was granted and assigned to MediciNova on February, 2012 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	8119657	February 21, 2012
	‌ US Patent 8420697 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom	Patent 8420697 was granted and assigned to MediciNova on April, 2013 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	8420697	April 16, 2013
	‌ US Patent 8026282 Phenoxyalkylcarboxylic acid derivatives in the treatment of irritable bowel syndrome	Patent 8026282 was granted and assigned to MediciNova on September, 2011 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	8026282	September 27, 2011
	‌ US Patent 8835499 Method of treating non-alcoholic fatty liver disease and steatohepatitis	Patent 8835499 was granted and assigned to MediciNova on September, 2014 by the United States Patent and Trademark Office.	MediciNova	MediciNova		United States Patent and Trademark Office	8835499	September 16, 2014
	‌ US Patent 8338453 Treatment of progressive neurodegenerative disease with ibudilast	Patent 8338453 was granted and assigned to MediciNova on December, 2012 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	8338453	December 25, 2012
	‌ US Patent 7365224 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use	Patent 7365224 was granted and assigned to MediciNova on April, 2008 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7365224	April 29, 2008
	‌ US Patent 7153993 Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid	Patent 7153993 was granted and assigned to MediciNova on December, 2006 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7153993	December 26, 2006
	‌ US Patent 7786169 Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis	Patent 7786169 was granted and assigned to MediciNova on August, 2010 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7786169	August 31, 2010
	‌ US Patent 8518995 Methods and compositions for the treatment of irritable bowel syndrome			MediciNova		United States Patent and Trademark Office	8518995	August 27, 2013
	‌ US Patent 7064146 Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use	Patent 7064146 was granted and assigned to MediciNova on June, 2006 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7064146	June 20, 2006
	‌ US Patent 7060854 Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid	Patent 7060854 was granted and assigned to MediciNova on June, 2006 by the United States Patent and Trademark Office.		MediciNova		United States Patent and Trademark Office	7060854	June 13, 2006
	‌ US Patent 11925625 Methods of treating chemical gas exposure	Patent 11925625 was granted and assigned to MediciNova on March, 2024 by the United States Patent and Trademark Office.	MediciNova	MediciNova		United States Patent and Trademark Office	11925625	March 12, 2024
	‌ US Patent 11944607 Treatment of progressive neurodegenerative disease with ibudilast	Patent 11944607 was granted and assigned to MediciNova on April, 2024 by the United States Patent and Trademark Office.	MediciNova	MediciNova		United States Patent and Trademark Office	11944607	April 2, 2024
	‌ US Patent 11865214 Ibudilast oral formulations and methods of using same	Patent 11865214 was granted and assigned to MediciNova on January, 2024 by the United States Patent and Trademark Office.	MediciNova	MediciNova		United States Patent and Trademark Office	11865214	January 9, 2024

18 results

0 selected

18 results

0 selected